Name: VYNE THERAPEUTICS INC (VYNE) Stock
Brand: VYNE THERAPEUTICS INC
Rating: 4.5 (3 reviews)

VYNE Latest News, Press Relases and Analysis

All

Press Releases

6 days ago - By: Benzinga - Mentions: AIM NUVL GLMD VTGN ...

12 Health Care Stocks Moving In Monday's After-Market Session

17 days ago - By: VYNE Therapeutics Inc.

VYNE Therapeutics Reports 2025 Third Quarter Financial Results and Provides Business Update

3 months ago - By: Zacks Investment Research - Mentions: CASI

VYNE Therapeutics Inc. (VYNE) Reports Q2 Loss, Lags Revenue Estimates

3 months ago - By: The Motley Fool

VYNE Reports Narrower Loss in Fiscal Q2

3 months ago - By: VYNE Therapeutics Inc.

VYNE Therapeutics Reports 2025 Second Quarter Financial Results and Provides Business Update

3 months ago - By: Zacks Investment Research - Mentions: MGX

Metagenomi (MGX) Reports Q2 Loss, Tops Revenue Estimates

3 months ago - By: Zacks Investment Research - Mentions: AQST

Aquestive Therapeutics (AQST) Reports Q2 Loss, Lags Revenue Estimates

4 months ago - By: Zacks Investment Research - Mentions: CPRX

Catalyst Pharmaceutical (CPRX) Q2 Earnings and Revenues Surpass Estimates

4 months ago - By: Benzinga - Mentions: PBM IDXX EQ REPL ...

12 Health Care Stocks Moving In Monday's Pre-Market Session

4 months ago - By: Stocktwits

Vyne Hit With Downgrades After Repibresib Misses Endpoints In Vitiligo Trial; Traders Still Eye Rebound

4 months ago - By: Yahoo Finance

VYNE Therapeutics Inc. (VYNE) Gets Buy Reaffirmation on Pipeline Progress

5 months ago - By: VYNE Therapeutics Inc.

VYNE Therapeutics Provides Program Update on Oral BET inhibitor VYN202

7 months ago - By: VYNE Therapeutics Inc.

VYNE Therapeutics Reports 2025 First Quarter Financial Results and Provides Business Update